2020
DOI: 10.3390/mi11070648
|View full text |Cite
|
Sign up to set email alerts
|

A 3D-Printed Modular Microreservoir for Drug Delivery

Abstract: Reservoir-based drug delivery microsystems have enabled novel and effective drug delivery concepts in recent decades. These systems typically comprise integrated storing and pumping components. Here we present a stand-alone, modular, thin, scalable, and refillable microreservoir platform as a storing component of these microsystems for implantable and transdermal drug delivery. Three microreservoir capacities (1, 10, and 100 µL) were fabricated with 3 mm overall thickness using stereolithography 3D-pri… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
15
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 18 publications
(15 citation statements)
references
References 50 publications
0
15
0
Order By: Relevance
“…This would be highly useful for both in vitro and in vivo cases, where the source reservoir does not need to be kept sterile, while the sink reservoir can remain sterile for cell culture or tissue contact. This would further allow for using the source reservoir for replenishing pharmaceuticals (via several methods involving hypodermic needle-accessible membranes [ 2 , 13 , 71 ]) without having the remove the implanted devices. In addition, np-Au’s antimicrobial properties [ 72 ], compatibility with biomolecules and tissue [ 38 ], and reproducibility in manufacturing [ 41 ] fulfill aspects of the Safe-by-Design approach for nanobiomaterial development, which highlights np-Au’s potential for clinical translation [ 73 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This would be highly useful for both in vitro and in vivo cases, where the source reservoir does not need to be kept sterile, while the sink reservoir can remain sterile for cell culture or tissue contact. This would further allow for using the source reservoir for replenishing pharmaceuticals (via several methods involving hypodermic needle-accessible membranes [ 2 , 13 , 71 ]) without having the remove the implanted devices. In addition, np-Au’s antimicrobial properties [ 72 ], compatibility with biomolecules and tissue [ 38 ], and reproducibility in manufacturing [ 41 ] fulfill aspects of the Safe-by-Design approach for nanobiomaterial development, which highlights np-Au’s potential for clinical translation [ 73 ].…”
Section: Discussionmentioning
confidence: 99%
“…These drug delivery modalities have shown promise in overcoming several pharmaceutical challenges by improving permeation across the blood–brain barrier [ 8 ], reducing systemic side effects through targeted delivery at the site of interest [ 9 ], and maintaining the delivery dose within the therapeutic window for high efficacy and low toxicity [ 10 ]. One class of drug delivery technology is based on the use of macro-scale infusion pumps or miniaturized microelectromechanical systems (MEMS)-based pumps, where the delivery segment (e.g., cannula) and the reservoir can be both implanted [ 11 , 12 , 13 ]. In both cases, the pharmaceuticals are delivered in a liquid vehicle solution by convective means, which leads to the problem of potentially damaging increase of local pressure in the target tissue.…”
Section: Introductionmentioning
confidence: 99%
“…A novel, hybrid manufacturing process was developed for drug delivery systems incorporated with drug depots, where the matrix of the DDS was generated by SLA and loading of drug depots was done using inkjet printing ( 106 ). Microreservoirs for implantable and transdermal delivery were developed ( 107 ). Goyanes and associates developed salicylic acid–based anti-acne masks using FDM and SLA.…”
Section: D Printing Technologies Used In Pharmaceutical Developmentmentioning
confidence: 99%
“…Here, we present a low-cost, miniature, thin, programmable, and wirelessly controlled microsystem for implantable and transdermal drug delivery, fabricated with 3D-printing technology and enabling scalability for applications ranging from small animal models to clinical use in children and adults. We review the designs of the microreservoir and the micropump, which were published recently [35,36], along with describing modifications of the micropump fabrication process to improve long-term application suitability. The micropump and microreservoir were integrated in a single embodiment using 3Dprinting technology.…”
Section: Introductionmentioning
confidence: 99%
“…The entire interior surface of the microreservoir is coated with parylene-C, providing a class VI biocompatible environment for long-term drug storage. 3D-printing technology enables scalability in the range of 1-100 µL and integration to alternative pumping mechanisms by minimal change in the design [35].…”
Section: Introductionmentioning
confidence: 99%